3-hydroxybutyric acid has been researched along with Cryopyrin-Associated Periodic Syndromes in 4 studies
3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.
Cryopyrin-Associated Periodic Syndromes: A group of rare autosomal dominant diseases, commonly characterized by atypical URTICARIA (hives) with systemic symptoms that develop into end-organ damage. The atypical hives do not involve T-cell or autoantibody. Cryopyrin-associated periodic syndrome includes three previously distinct disorders: Familial cold autoinflammatory syndrome; Muckle-Wells Syndrome; and CINCA Syndrome, that are now considered to represent a disease continuum, all caused by NLRP3 PROTEIN mutations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Youm, YH | 1 |
| Nguyen, KY | 1 |
| Grant, RW | 1 |
| Goldberg, EL | 1 |
| Bodogai, M | 1 |
| Kim, D | 1 |
| D'Agostino, D | 1 |
| Planavsky, N | 1 |
| Lupfer, C | 1 |
| Kanneganti, TD | 1 |
| Kang, S | 1 |
| Horvath, TL | 1 |
| Fahmy, TM | 1 |
| Crawford, PA | 1 |
| Biragyn, A | 1 |
| Alnemri, E | 1 |
| Dixit, VD | 1 |
| Kugelberg, E | 1 |
| Netea, MG | 1 |
| Joosten, LA | 1 |
| Groß, CJ | 1 |
| Groß, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Keto-diet for Intubated Critical Care COVID-19 (KICC-COVID19)[NCT04358835] | 0 participants (Actual) | Interventional | 2020-09-01 | Withdrawn (stopped due to Study did not begin enrollment, multiple competing studies at same institution) | |||
| COVID-19 Vaccination in Subjects With Obesity: Impact of Metabolic Health and the Role of a Ketogenic Diet[NCT05163743] | 24 participants (Anticipated) | Interventional | 2021-05-23 | Recruiting | |||
| A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma[NCT05119010] | 60 participants (Anticipated) | Interventional | 2023-03-24 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for 3-hydroxybutyric acid and Cryopyrin-Associated Periodic Syndromes
| Article | Year |
|---|---|
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Perio | 2015 |
Inflammasome: starving inflammation.
Topics: 3-Hydroxybutyric Acid; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Periodic Syndromes | 2015 |
Inflammasome inhibition: putting out the fire.
Topics: 3-Hydroxybutyric Acid; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Periodic Syndromes | 2015 |
The Nlrp3 inflammasome admits defeat.
Topics: 3-Hydroxybutyric Acid; Animals; Carrier Proteins; Caspase 1; Cryopyrin-Associated Periodic Syndromes | 2015 |